These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

406 related items for PubMed ID: 21358347

  • 1. MicroRNAs dysregulation in human malignant pleural mesothelioma.
    Balatti V, Maniero S, Ferracin M, Veronese A, Negrini M, Ferrocci G, Martini F, Tognon MG.
    J Thorac Oncol; 2011 May; 6(5):844-51. PubMed ID: 21358347
    [Abstract] [Full Text] [Related]

  • 2. ZIC1 is silenced and has tumor suppressor function in malignant pleural mesothelioma.
    Cheng YY, Kirschner MB, Cheng NC, Gattani S, Klebe S, Edelman JJ, Vallely MP, McCaughan BC, Jin HC, van Zandwijk N, Reid G.
    J Thorac Oncol; 2013 Oct; 8(10):1317-28. PubMed ID: 24457242
    [Abstract] [Full Text] [Related]

  • 3. Circulating microRNAs found dysregulated in ex-exposed asbestos workers and pleural mesothelioma patients as potential new biomarkers.
    Bononi I, Comar M, Puozzo A, Stendardo M, Boschetto P, Orecchia S, Libener R, Guaschino R, Pietrobon S, Ferracin M, Negrini M, Martini F, Bovenzi M, Tognon M.
    Oncotarget; 2016 Dec 13; 7(50):82700-82711. PubMed ID: 27716620
    [Abstract] [Full Text] [Related]

  • 4. Functional Analysis of the Adrenomedullin Pathway in Malignant Pleural Mesothelioma.
    Greillier L, Tounsi A, Berenguer-Daizé C, Dussault N, Delfino C, Benyahia Z, Cayol M, Mabrouk K, Garcia S, Martin PM, Barlesi F, Ouafik L.
    J Thorac Oncol; 2016 Jan 13; 11(1):94-107. PubMed ID: 26762744
    [Abstract] [Full Text] [Related]

  • 5. Differential expression of extracellular matrix constituents and cell adhesion molecules between malignant pleural mesothelioma and mesothelial hyperplasia.
    Alì G, Borrelli N, Riccardo G, Proietti A, Pelliccioni S, Niccoli C, Boldrini L, Lucchi M, Mussi A, Fontanini G.
    J Thorac Oncol; 2013 Nov 13; 8(11):1389-95. PubMed ID: 24084442
    [Abstract] [Full Text] [Related]

  • 6. KCa1.1, a calcium-activated potassium channel subunit alpha 1, is targeted by miR-17-5p and modulates cell migration in malignant pleural mesothelioma.
    Cheng YY, Wright CM, Kirschner MB, Williams M, Sarun KH, Sytnyk V, Leshchynska I, Edelman JJ, Vallely MP, McCaughan BC, Klebe S, van Zandwijk N, Lin RC, Reid G.
    Mol Cancer; 2016 Jun 01; 15(1):44. PubMed ID: 27245839
    [Abstract] [Full Text] [Related]

  • 7. Plasmatic extracellular vesicle microRNAs in malignant pleural mesothelioma and asbestos-exposed subjects suggest a 2-miRNA signature as potential biomarker of disease.
    Cavalleri T, Angelici L, Favero C, Dioni L, Mensi C, Bareggi C, Palleschi A, Rimessi A, Consonni D, Bordini L, Todaro A, Bollati V, Pesatori AC.
    PLoS One; 2017 Jun 01; 12(5):e0176680. PubMed ID: 28472171
    [Abstract] [Full Text] [Related]

  • 8. MicroRNA signature of malignant mesothelioma with potential diagnostic and prognostic implications.
    Busacca S, Germano S, De Cecco L, Rinaldi M, Comoglio F, Favero F, Murer B, Mutti L, Pierotti M, Gaudino G.
    Am J Respir Cell Mol Biol; 2010 Mar 01; 42(3):312-9. PubMed ID: 19502386
    [Abstract] [Full Text] [Related]

  • 9. Analysis of microRNA expression signatures in malignant pleural mesothelioma, pleural inflammation, and atypical mesothelial hyperplasia reveals common predictive tumorigenesis-related targets.
    Ramírez-Salazar EG, Salinas-Silva LC, Vázquez-Manríquez ME, Gayosso-Gómez LV, Negrete-Garcia MC, Ramírez-Rodriguez SL, Chávez R, Zenteno E, Santillán P, Kelly-García J, Ortiz-Quintero B.
    Exp Mol Pathol; 2014 Dec 01; 97(3):375-85. PubMed ID: 25236577
    [Abstract] [Full Text] [Related]

  • 10. Diagnostic potential of miR-126, miR-143, miR-145, and miR-652 in malignant pleural mesothelioma.
    Andersen M, Grauslund M, Ravn J, Sørensen JB, Andersen CB, Santoni-Rugiu E.
    J Mol Diagn; 2014 Jul 01; 16(4):418-30. PubMed ID: 24912849
    [Abstract] [Full Text] [Related]

  • 11. Tumor Suppressor microRNAs Contribute to the Regulation of PD-L1 Expression in Malignant Pleural Mesothelioma.
    Kao SC, Cheng YY, Williams M, Kirschner MB, Madore J, Lum T, Sarun KH, Linton A, McCaughan B, Klebe S, van Zandwijk N, Scolyer RA, Boyer MJ, Cooper WA, Reid G.
    J Thorac Oncol; 2017 Sep 01; 12(9):1421-1433. PubMed ID: 28629895
    [Abstract] [Full Text] [Related]

  • 12. Polycomb repressor complex-2 is a novel target for mesothelioma therapy.
    Kemp CD, Rao M, Xi S, Inchauste S, Mani H, Fetsch P, Filie A, Zhang M, Hong JA, Walker RL, Zhu YJ, Ripley RT, Mathur A, Liu F, Yang M, Meltzer PA, Marquez VE, De Rienzo A, Bueno R, Schrump DS.
    Clin Cancer Res; 2012 Jan 01; 18(1):77-90. PubMed ID: 22028491
    [Abstract] [Full Text] [Related]

  • 13. Secreted and Tissue miRNAs as Diagnosis Biomarkers of Malignant Pleural Mesothelioma.
    Martínez-Rivera V, Negrete-García MC, Ávila-Moreno F, Ortiz-Quintero B.
    Int J Mol Sci; 2018 Feb 17; 19(2):. PubMed ID: 29462963
    [Abstract] [Full Text] [Related]

  • 14. Dysregulated Expression of the MicroRNA miR-137 and Its Target YBX1 Contribute to the Invasive Characteristics of Malignant Pleural Mesothelioma.
    Johnson TG, Schelch K, Cheng YY, Williams M, Sarun KH, Kirschner MB, Kao S, Linton A, Klebe S, McCaughan BC, Lin RCY, Pirker C, Berger W, Lasham A, van Zandwijk N, Reid G.
    J Thorac Oncol; 2018 Feb 17; 13(2):258-272. PubMed ID: 29113949
    [Abstract] [Full Text] [Related]

  • 15. Kinesin family members KIF11 and KIF23 as potential therapeutic targets in malignant pleural mesothelioma.
    Kato T, Lee D, Wu L, Patel P, Young AJ, Wada H, Hu HP, Ujiie H, Kaji M, Kano S, Matsuge S, Domen H, Kaga K, Matsui Y, Kanno H, Hatanaka Y, Hatanaka KC, Matsuno Y, de Perrot M, Yasufuku K.
    Int J Oncol; 2016 Aug 17; 49(2):448-56. PubMed ID: 27279560
    [Abstract] [Full Text] [Related]

  • 16. Increased circulating miR-625-3p: a potential biomarker for patients with malignant pleural mesothelioma.
    Kirschner MB, Cheng YY, Badrian B, Kao SC, Creaney J, Edelman JJ, Armstrong NJ, Vallely MP, Musk AW, Robinson BW, McCaughan BC, Klebe S, Mutsaers SE, van Zandwijk N, Reid G.
    J Thorac Oncol; 2012 Jul 17; 7(7):1184-91. PubMed ID: 22617246
    [Abstract] [Full Text] [Related]

  • 17. Association of MiR-126 with soluble mesothelin-related peptides, a marker for malignant mesothelioma.
    Santarelli L, Strafella E, Staffolani S, Amati M, Emanuelli M, Sartini D, Pozzi V, Carbonari D, Bracci M, Pignotti E, Mazzanti P, Sabbatini A, Ranaldi R, Gasparini S, Neuzil J, Tomasetti M.
    PLoS One; 2011 Apr 01; 6(4):e18232. PubMed ID: 21483773
    [Abstract] [Full Text] [Related]

  • 18. CDKN2A, NF2, and JUN are dysregulated among other genes by miRNAs in malignant mesothelioma -A miRNA microarray analysis.
    Guled M, Lahti L, Lindholm PM, Salmenkivi K, Bagwan I, Nicholson AG, Knuutila S.
    Genes Chromosomes Cancer; 2009 Jul 01; 48(7):615-23. PubMed ID: 19396864
    [Abstract] [Full Text] [Related]

  • 19. Expression profiling stratifies mesothelioma tumors and signifies deregulation of spindle checkpoint pathway and microtubule network with therapeutic implications.
    Suraokar MB, Nunez MI, Diao L, Chow CW, Kim D, Behrens C, Lin H, Lee S, Raso G, Moran C, Rice D, Mehran R, Lee JJ, Pass HI, Wang J, Momin AA, James BP, Corvalan A, Coombes K, Tsao A, Wistuba II.
    Ann Oncol; 2014 Jun 01; 25(6):1184-92. PubMed ID: 24669013
    [Abstract] [Full Text] [Related]

  • 20. Methylation-associated Silencing of microRNA-126 and its Host Gene EGFL7 in Malignant Pleural Mesothelioma.
    Andersen M, Trapani D, Ravn J, Sørensen JB, Andersen CB, Grauslund M, Santoni-Rugiu E.
    Anticancer Res; 2015 Nov 01; 35(11):6223-9. PubMed ID: 26504055
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.